HomeAI · summaries
Storia in 11 fonti
GLP-1s may lower breast cancer risk in women by 30%, new study suggests
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWeight-loss jabs have risen in popularity (Alamy/PA) (Alamy/PA)A new study from the University of Pennsylvania Perelman School of Medicine found that women taking GLP-1 weight loss drugs like Ozempic and Wegovy had a 30 percent reduced risk of developing breast cancer. These findings build on previous research linking GLP-1 use to improved outcomes for various cancers, suggesting a broader potential for cancer prevention. The observational study analyzed health data from over 110,000 overweight American women aged 45 to 80 between 2022 and 2025, with 15,264 participants initially using GLP-1 medications. Researchers, including Dr. Elizabeth McDonald, emphasize that while the study does not definitively confirm a direct association, it warrants further investigation into these drugs as cancer prevention tools. The potential mechanisms behind this reduced risk include the drugs' ability to promote weight loss and reduce inflammation, both of which are known risk factors for breast cancer. In fullWomen taking GLP-1 drugs 30 percent less likely to develop breast cancer, researchers sayThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
sciencedaily.com
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.…
- ·
theguardian.com
Weight-loss drugs can cut breast cancer risk by up to 30%, studies suggest
Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease
- ·
dailymail.com
Weight-loss jabs could cut breast cancer risk by nearly a third
Weight loss jabs could significantly lower the risk of breast cancer , even in those considered at high risk of the disease, a landmark study has suggested.
- ·
abc.es
El uso de Ozempic se asocia con una reducción del 30 % en la incidencia de cáncer de mama
Un estudio observacional con más de 110 000 mujeres abre la puerta a utilizar estos populares medicamentos para la pérdida de peso como prevención oncológica.
- ·
independent.co.uk
Women on GLP-1 drugs 30 percent less likely to develop breast cancer
About 42,140 women are expected to die from breast cancer in the U.S. this year
- ·
GLP-1s may lower breast cancer risk in women by 30%, new study suggests
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWeight-loss jabs have risen in popularity…
- ·
Weight loss drugs could prevent knee replacement surgery, study finds
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleNew research indicates that weight loss…
- ·
newsbytesapp.com
Weight loss drugs can protect you from breast cancer
Weight-loss drugs may reduce breast cancer risk by up to 30%, according to three studies, highlighting their potential role in lowering cancer development and mortality rates.
- ·
abcnews.com
Doctor breaks down study showing GLP-1s may lower breast cancer risk
A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast cancer by about 30%.
- ·
channelnewsasia.com
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer
More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm…
- ·
euronews.com
Weight-loss drugs linked to lower breast cancer risk, study finds
Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study.
- ·
medpagetoday.com
Accumulating Evidence Lifts GLP-1s to Clinical Trial for Breast Cancer Prevention
Use of drugs for overweight/obesity linked to lower risk of breast cancer, several leukemias
- ·
sciencealert.com
Popular Weight Loss Drugs Linked to Lower Risk of Breast Cancer
The potential benefits of GLP-1 drugs, like Ozempic or Wegovy, are stacking up.